Clinical Trial Update: Tenecteplase in Patients With COVID-19 [Phase 2]

View source ↗

Summary

Phase 2 trial update for tenecteplase in COVID-19 patients with respiratory failure completed, with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Distress Syndrome
• Respiratory Failure

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Hooman Poor | Conditions: COVID-19, Respiratory Failure | Phase 2 | Status: COMPLETED | Results posted: 2023-04-06